Seek

Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments

Retrieved on: 
월요일, 5월 6, 2024

Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based technologies to target the African Swine Fever Virus (ASFV) in pigs.

Key Points: 
  • Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based technologies to target the African Swine Fever Virus (ASFV) in pigs.
  • The trial, which aimed to replicate and expand an earlier trial, demonstrated pigs infected with ASFV and treated with Seek Labs’ CRISPR-based systems survived longer than untreated infected pigs.
  • With no available treatments for African Swine Fever, this is a breakthrough discovery.
  • Seek Labs’ work represents a beacon of hope for the swine industry and underscores the transformative potential of CRISPR-based technology in global healthcare.

Seek Labs Appoints Renowned Life Sciences Innovator, Dr. Michael Paul, PhD, to Board of Directors

Retrieved on: 
화요일, 3월 19, 2024

With decades of experience in life sciences innovation, capital formation, and management, Dr. Paul brings industry insight and visionary leadership to accelerate Seek Labs’ growth, strategic initiatives, and research.

Key Points: 
  • With decades of experience in life sciences innovation, capital formation, and management, Dr. Paul brings industry insight and visionary leadership to accelerate Seek Labs’ growth, strategic initiatives, and research.
  • Dr. Paul has made significant contributions to the life sciences industry through groundbreaking innovation and strategic leadership.
  • "We are honored to be joined by Dr. Michael Paul on our Board,” said Jared Bauer, CEO.
  • “I am excited to join the Board of Directors of Seek Labs, a company that is setting the bar for diagnostic and pharmaceutical innovation,” said Dr. Paul.

Seek Labs Welcomes Cindy Dunkle, Accomplished HR Leader with Extensive Life Sciences Experience, to Board of Directors

Retrieved on: 
화요일, 2월 27, 2024

Dunkle brings decades of life sciences leadership experience and connections that will enhance Seek Labs’ strategic direction and employee-centered approach.

Key Points: 
  • Dunkle brings decades of life sciences leadership experience and connections that will enhance Seek Labs’ strategic direction and employee-centered approach.
  • Dunkle is widely recognized for her profound understanding of human capital management in the life sciences sector.
  • Jared Bauer, CEO, expressed his enthusiasm to have Dunkle join Seek Labs’ Board: “We are thrilled to have Cindy Dunkle join our Board of Directors.
  • "I am honored to join Seek Labs’ Board of Directors at a pivotal moment as the company continues to grow and expand its footprint in the life sciences and biotechnology industry,” said Cindy Dunkle.

Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research

Retrieved on: 
목요일, 2월 22, 2024

Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced today the appointment of Alison O’Mahony, PhD as Vice President of Pharmaceutical Development.

Key Points: 
  • Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced today the appointment of Alison O’Mahony, PhD as Vice President of Pharmaceutical Development.
  • With nearly 20 years of experience in R&D, phenotypic drug discovery, and assay and scientific operations, O’Mahony brings extensive knowledge and expertise to Seek Labs where she will spearhead the pharmaceutical research division, leading strategic initiatives to advance Seek Labs’ innovation in novel gene therapies.
  • "We are delighted to welcome Alison O’Mahony to Seek Labs as our new Vice President of Pharmaceutical Development," said Jared Bauer, CEO.
  • She also serves on professional boards including Talent Ready Utah, Breakthrough Cancer Research, and the Inflammation Research Association.

California Water Service Awards More Than $186,000 in Grants to Eight Fire Departments

Retrieved on: 
수요일, 11월 29, 2023

SAN JOSE, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- To support local fire departments and their efforts to provide rescue and emergency services, California Water Service (Cal Water) today announced it will award $186,077 in grants to eight California fire departments as part of the utility’s fifth annual Firefighter Grant Program.

Key Points: 
  • SAN JOSE, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- To support local fire departments and their efforts to provide rescue and emergency services, California Water Service (Cal Water) today announced it will award $186,077 in grants to eight California fire departments as part of the utility’s fifth annual Firefighter Grant Program.
  • “As a water provider, day in and day out we work together with fire departments in our service areas to supply the water and pressure they need to extinguish fires and save lives and property,” said Martin A. Kropelnicki, Cal Water President and CEO.
  • That’s one of the reasons Cal Water has tripled its grant funding from the $60,000 it originally allocated.
  • The firefighter grants are funded through Cal Water’s philanthropic giving program and do not impact customer rates.

SeekCoin is Set to Revolutionize How We Perceive Cryptocurrency Utility in the Future

Retrieved on: 
목요일, 10월 5, 2023

BELIZE CITY, Belize, Oct. 5, 2023 /PRNewswire/ -- SeekCoin, a novel crypto ecosystem project, is setting itself up to reach the world stage with its feature-rich native tokens and a plethora of applications. The ecosystem has a native token and platforms for crypto swapping, e-commerce, crypto advertising, staking, and lottery where the native token can be utilized.

Key Points: 
  • The new-gen crypto project SeekCoin is set to redefine the use of cryptocurrencies in the real world through its rich utilities.
  • So far, the project has completed the token presale and is gearing towards a full-scale launch anticipated soon.
  • With thousands of token holders, SEEK is already defining its competitive edge in the cryptocurrency market.
  • With exciting benefits and a unique system to enhance value, SeekCoin is well-positioned to rule the crypto markets in the future.

Announcing Seek Enrich: Revolutionizing Insight Development in the CPG Industry

Retrieved on: 
화요일, 9월 19, 2023

“When I was a vendor, we were in a perpetual hunt for ways to find an edge against our competition -- enriched data-driven insights were costly and near impossible to build out back then.” - Sean Cline, CPG Industry Expert, Seek.

Key Points: 
  • “When I was a vendor, we were in a perpetual hunt for ways to find an edge against our competition -- enriched data-driven insights were costly and near impossible to build out back then.” - Sean Cline , CPG Industry Expert, Seek.
  • Since the launch of Seek’s Insight Cloud, Seek has developed strong strategic partnerships with industry-changing data providers, directly contributing to the platform customer’s successes.
  • Seek Enrich takes those partnerships one step further- giving instant access to data sets, that have been often unleveraged due to price and complexity of integration, to CPG brands.
  • Seek Enrich is truly a “win-win” for both our partners and our customers!” Jonny Kibler , VP of Partnerships, Seek

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

Retrieved on: 
수요일, 8월 30, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230829323192/en/
    The European Commission (EC) will review the CHMP’s recommendation and is expected to make a final decision soon.
  • Following a decision from the EC, the updated vaccine will be ready to ship to applicable EU member states immediately.
  • “Omicron XBB-related sublineages are antigenically distant from prior Omicron strains and continue to account for the vast majority of COVID-19 cases globally.
  • Further, the application included pre-clinical data showing that the Omicron XBB.1.5-adapted monovalent COVID-19 vaccine generates a substantially improved response against multiple XBB sublineages, including XBB.1.5, XBB.1.16, and XBB.2.3, compared to the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine.

Seek Becomes One of the First to Achieve Elite Partner Status in Multiple Programs With Snowflake

Retrieved on: 
월요일, 6월 12, 2023

As an Elite tier partner, Seek is leveraging their unique portfolio of technology, data, and professional services to empower customers to become more ‘insight-driven’ with Snowflake’s Data Cloud.

Key Points: 
  • As an Elite tier partner, Seek is leveraging their unique portfolio of technology, data, and professional services to empower customers to become more ‘insight-driven’ with Snowflake’s Data Cloud.
  • Seek helps customers accelerate ROI from their data cloud ecosystems by accelerating data acquisition, deploying turnkey industry-specific applications at scale (through the Seek Insight Cloud platform), and developing cutting-edge custom solutions with Snowflake.
  • The Snowflake Partner Network unlocks the potential of the Data Cloud with a broad array of tools and partners.
  • To become a Snowflake partner and get access to Snowflake’s self-service partner resources, please click here .

Senna invests in rebranding and expanding its business in the US and Europe

Retrieved on: 
금요일, 5월 26, 2023

SÃO PAULO, May 26, 2023 /PRNewswire/ -- Founded by Ayrton Senna, the Senna Brand was created to inspire people by the driver's lifestyle . After 33 years, its new positioning encourages people to pursue their dreams. With a new visual identity and the slogan "Seek Your Truth", the brand reinforces Ayrton's legacy for fans and new generations.

Key Points: 
  • SÃO PAULO, May 26, 2023 /PRNewswire/ -- Founded by Ayrton Senna, the Senna Brand was created to inspire people by the driver's lifestyle .
  • With a new visual identity and the slogan "Seek Your Truth", the brand reinforces Ayrton's legacy for fans and new generations.
  • Brand new collaborations, such as the series in partnership with Netflix scheduled for 2024, reinforce the rebranding.
  • The Seek collection was created by fans of the driver, who continue to seek their best version of themselves.